Immune responses in mildly versus critically ill COVID-19 patients
H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …
devastating effects on the global health and economic system. The cellular and molecular …
Antibody responses to natural SARS-CoV-2 infection or after COVID-19 vaccination
H Altawalah - Vaccines, 2021 - mdpi.com
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma …
Elucidating the characteristics of human immune response against SARS-CoV-2 is of high
priority and relevant for determining vaccine strategies. We report the results of a follow-up …
priority and relevant for determining vaccine strategies. We report the results of a follow-up …
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study
H Amellal, N Assaid, H Charoute, K Akarid, A Maaroufi… - Plos one, 2023 - journals.plos.org
Coronavirus 2019 (COVID-19) is a global health threat. The kinetics of antibodies against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) need to be assessed, as …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) need to be assessed, as …
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
EC Abebe, TA Dejenie - Frontiers in Immunology, 2023 - frontiersin.org
Neutralizing antibodies (NAbs) are central players in the humoral immunity that defends the
body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their …
body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their …
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with
unprecedented strain on health care systems. To investigate the time course of the antibody …
unprecedented strain on health care systems. To investigate the time course of the antibody …
[HTML][HTML] Humoral immunity against SARS-CoV-2 and the impact on COVID-19 pathogenesis
E Lee, JE Oh - Molecules and cells, 2021 - Elsevier
It has been more than a year since severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) first emerged. Many studies have provided insights into the various aspects of the …
CoV-2) first emerged. Many studies have provided insights into the various aspects of the …
Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort
P Ruytinx, P Vandormael, J Fraussen, Z Pieters… - Scientific Reports, 2023 - nature.com
The immune response in patients with Coronavirus Disease 2019 (COVID-19) is highly
variable and is linked to disease severity and mortality. However, antibody and cytokine …
variable and is linked to disease severity and mortality. However, antibody and cytokine …
Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
M Choteau, A Scohy, S Messe, M Luyckx… - Scientific reports, 2022 - nature.com
More than a year after the start of the pandemic, COVID-19 remains a global health
emergency. Although the immune response against SARS-CoV-2 has been extensively …
emergency. Although the immune response against SARS-CoV-2 has been extensively …
Kinetics of SARS-CoV-2 IgM and IgG antibodies 3 months after COVID-19 onset in Moroccan patients
N Assaid, S Arich, H Charoute, K Akarid… - … American Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) poses serious global public health problems. Characterization of the …
2 (SARS-CoV-2) poses serious global public health problems. Characterization of the …